New 'See and Treat' cancer approach enters human testing

NCT ID NCT06389123

Recruiting now Disease control Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Mar 05, 2026 · Last updated May 16, 2026 · Updated 10 times

Summary

This early-stage study tests a new method to both detect and treat metastatic cancers (cancers that have spread). The approach uses a special molecule that targets a protein found on many cancer cells. First, a radioactive imaging agent helps locate tumors. Then, a therapeutic radioactive dose is given to try to destroy them. The study involves 40 adults with certain advanced cancers and focuses on safety and whether the treatment shrinks tumors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The University of California Davis Comprehensive Cancer Center
RECRUITING

Sacramento, California, 95817, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC CANCER